Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1986-10-22
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0007-0947
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
40
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
273-5
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:3741741-Aged,
pubmed-meshheading:3741741-Drug Therapy, Combination,
pubmed-meshheading:3741741-Female,
pubmed-meshheading:3741741-Humans,
pubmed-meshheading:3741741-Levodopa,
pubmed-meshheading:3741741-Male,
pubmed-meshheading:3741741-Middle Aged,
pubmed-meshheading:3741741-Orphenadrine,
pubmed-meshheading:3741741-Parkinson Disease
|
pubmed:year |
1986
|
pubmed:articleTitle |
Treatment of Parkinson's disease with orphenadrine alone and in combination with L-dopa.
|
pubmed:publicationType |
Journal Article
|